RDF/XML JSON-LD N3/Turtle RDF/JSON

Ruano Gallego, David david.ruanog@uam.es

Biología molecular / Universidad Autónoma de Madrid

Publications

The type III secretion system effector network hypothesis

  • Sanchez-Garrido J
  • Ruano-Gallego D
  • Choudhary JS
  • Frankel G

Trends In Microbiology (p. 524-533) - 1/6/2022

10.1016/j.tim.2021.10.007 View at source

  • ISSN 0966842X

Targeted bacterial conjugation mediated by synthetic cell-to-cell adhesions

  • Robledo M, Álvarez B, Cuevas A, González S, Ruano-Gallego D, Fernández LÁ, de la Cruz F

Nucleic Acids Research (p. 12938-12950) - 9/12/2022

  • ISSN 03051048
  • iMarina

A multiplex antigen microarray for simultaneous IgG and IgM detection against SARS-CoV-2 reveals higher seroprevalence than reported

  • Ruano-Gallego D
  • García-Villadangos M
  • Moreno-Paz M
  • Gómez-Elvira J
  • Postigo M
  • Simón-Sacristán M
  • Reyburn HT
  • Carolis C
  • Rodrigo N
  • Codeseira YB
  • Rueda P
  • Zúñiga S
  • Enjuanes L
  • Parro V
... View more Collapse

Microbial Biotechnology (p. 1228-1236) - 1/5/2021

10.1111/1751-7915.13801 View at source

  • ISSN 17517907

Type III secretion system effectors form robust and flexible intracellular virulence networks

  • Ruano-Gallego D
  • Sanchez-Garrido J
  • Kozik Z
  • Núñez-Berrueco E
  • Cepeda-Molero M
  • Mullineaux-Sanders C
  • Clark JNB
  • Slater SL
  • Wagner N
  • Glegola-Madejska I
  • Roumeliotis TI
  • Pupko T
  • Fernández LÁ
  • Rodríguez-Patón A
  • Choudhary JS
  • Frankel G
... View more Collapse

Science (p. 1122-+) - 1/1/2021

10.1126/science.abc9531 View at source

  • ISSN 00368075

Faecal neutrophil elastase-antiprotease balance reflects colitis severity

  • Barry R
  • Ruano-Gallego D
  • Radhakrishnan ST
  • Lovell S
  • Yu L
  • Kotik O
  • Glegola-Madejska I
  • Tate EW
  • Choudhary JS
  • Williams HRT
  • Frankel G
... View more Collapse

Mucosal Immunology (p. 322-333) - 1/3/2020

10.1038/s41385-019-0235-4 View at source

  • ISSN 19330219

Enteropathogenic Escherichia coli Stimulates Effector-Driven Rapid Caspase-4 Activation in Human Macrophages

  • Goddard PJ
  • Sanchez-Garrido J
  • Slater SL
  • Kalyan M
  • Ruano-Gallego D
  • Marchès O
  • Fernández LÁ
  • Frankel G
  • Shenoy AR
... View more Collapse

Cell Reports (p. 1008-1017.e6) - 23/4/2019

10.1016/j.celrep.2019.03.100 View at source

  • ISSN 22111247

Screening and purification of nanobodies from E. coli culture supernatants using the hemolysin secretion system

  • Ruano-Gallego D
  • Fraile S
  • Gutierrez C
  • Fernández LÁ

Microbial Cell Factories - 11/3/2019

10.1186/s12934-019-1094-0 View at source

  • ISSN 14752859

A nanobody targeting the translocated intimin receptor inhibits the attachment of enterohemorrhagic E. coli to human colonic mucosa

  • Ruano-Gallego, David
  • Yara, Daniel A.
  • Di Ianni, Lorenza
  • Frankel, Gad
  • Schuller, Stephanie
  • Angel Fernandez, Luis;

Plos Pathogens - 1/1/2019

10.1371/journal.ppat.1008031 View at source

  • ISSN 15537366

Host-associated niche metabolism controls enteric infection through fine-tuning the regulation of type 3 secretion

  • Connolly JPR
  • Slater SL
  • O’Boyle N
  • Goldstone RJ
  • Crepin VF
  • Gallego DR
  • Herzyk P
  • Smith DGE
  • Douce GR
  • Frankel G
  • Roe AJ
... View more Collapse

Nature Communications - 1/12/2018

10.1038/s41467-018-06701-4 View at source

  • ISSN 20411723

Erratum to: Host-associated niche metabolism controls enteric infection through fine-tuning the regulation of type 3 secretion (Nature Communications, (2018), 9, 1, (4187), 10.1038/s41467-018-06701-4)

  • Connolly JPR
  • Slater SL
  • O’Boyle N
  • Goldstone RJ
  • Crepin VF
  • Ruano-Gallego D
  • Herzyk P
  • Smith DGE
  • Douce GR
  • Frankel G
  • Roe AJ
... View more Collapse

Nature Communications - 1/12/2018

10.1038/s41467-018-07612-0 View at source

  • ISSN 20411723

This researcher has no books.

Identification of Nanobodies Blocking Intimate Adherence of Shiga Toxin-Producing Escherichia coli to Epithelial Cells

  • Ruano-Gallego D
  • Fernández LÁ

Methods In Molecular Biology (p. 253-272) - 1/1/2021

10.1007/978-1-0716-1339-9_11 View at source

  • ISSN 10643745

Engineering E. coli to Combat Cancer

  • ;

Microbial Infections And Cancer Therapy (p. 1-448) - 1/1/2019

10.1201/9781351041904 View at source

Engineering Escherichia coli to Combat Cancer

  • Pinero-Lambea, Carlos
  • Ruano-Gallego, David
  • Bodelon, Gustavo
  • Alvarez, Beatriz
  • Angel Fernandez, Luis;

Microbial Infections And Cancer Therapy (p. 253-289) - 1/1/2019

  • iMarina

The type III secretion system of pathogenic escherichia coli

  • Slater SL
  • Sågfors AM
  • Pollard DJ
  • Ruano-Gallego D
  • Frankel G

Current Topics In Microbiology And Immunology (p. 51-72) - 1/1/2018

https://doi.org/10.1007/82_2018_116 View at source

  • ISSN 0070217X

Advanced A English

  • RUANO GALLEGO, DAVID

  • iMarina

Basic MATLAB

  • RUANO GALLEGO, DAVID

  • iMarina

Basic Python

  • RUANO GALLEGO, DAVID

  • iMarina

Biología Vascular, investigación básica y clínica en 2008

  • RUANO GALLEGO, DAVID

  • iMarina

CAE preparation course

  • RUANO GALLEGO, DAVID

  • iMarina

Flow Cytometry Course

  • RUANO GALLEGO, DAVID

  • iMarina

Las dimensiones de la Ciencia

  • RUANO GALLEGO, DAVID

  • iMarina

Lo que necesitas saber sobre la Investigación Cardiovascular

  • RUANO GALLEGO, DAVID

  • iMarina

Making the most of your postdoc

  • RUANO GALLEGO, DAVID

  • iMarina

María de Maeztu Academy CAB 2020-2021

  • RUANO GALLEGO, DAVID

  • iMarina

This researcher has no working papers.

This researcher has no technical reports.

Ayudas Ramón y Cajal

  • David Ruano Gallego (Investigador principal (IP))
  • RUANO GALLEGO, DAVID (Investigador principal (IP))

Period: 01-01-2023 - 31-12-2027

Type of funding: National

Amount of funding: 42000,00 Euros.

  • iMarina

Past and present signs of life detection in planetary exploration (SOLID)

  • RUANO GALLEGO, DAVID (Miembro de equipo)

Period: 01-01-2022 - 01-01-2025

Type of funding: National

Amount of funding: 181500,00 Euros.

  • iMarina

Maisha enterprise: an inhabitability Decision Tree for extrasolar planets

  • Ruano Gallego David
  • Alberto Álvarez Saavedra
  • Cristina Escudero Parada
  • Mercedes Moreno Paz
  • Patricia Cruz
  • Jorge Lillo Box (Investigador principal (IP))
  • RUANO GALLEGO, DAVID (Investigador principal (IP))
... View more Collapse

Period: 15-06-2021 - 01-01-2022

Type of funding: National

Amount of funding: 5000,00 Euros.

  • iMarina

Detección de señales de vida en exploración planetaria

  • Víctor Parro
  • Mercedes Moreno Paz (Investigador principal (IP))
  • RUANO GALLEGO, DAVID (Miembro de equipo)

Period: 01-01-2019 - 01-01-2022

Type of funding: National

  • iMarina

The temporal changes to cellular bioenergetics, cholesterol metabolism, innate immune responses and microbiota during infection

  • Gad Frankel (Investigador principal (IP))
  • RUANO GALLEGO, DAVID (Miembro de equipo)

Period: 01-01-2019 - 01-01-2024

  • iMarina

Deconstructing Citrobacter rodentium pathogenesis.

  • Gad Frankel (Investigador principal (IP))
  • RUANO GALLEGO, DAVID (Miembro de equipo)

Period: 01-04-2015 - 01-04-2020

Amount of funding: 1651743,00 Euros.

  • iMarina

Angiobodies 2.0: Desarrollo de anticuerpos recombinantes para uso terapéutico y diagnostico en angiogénesis patológica y para la identificación de nuevos marcadores angiogénicos

  • Luis Ángel Fernández Herrero (Investigador principal (IP))
  • RUANO GALLEGO, DAVID (Miembro de equipo)

Period: 01-01-2012 - 01-01-2016

Amount of funding: 515200,00 Euros.

  • iMarina

Desarrollos para la aplicación in vivo de la adhesión sintética e inyección específica de anticuerpps monodominio y otras proteínas en células humanas por E.coli

  • Luis Ángel Fernández Herrero (Investigador principal (IP))
  • RUANO GALLEGO, DAVID (Miembro de equipo)

Period: 01-01-2012 - 01-01-2015

Amount of funding: 229900,00 Euros.

  • iMarina

Combinando los sistemas de secreción de proteínas de Escherichia coli con la tecnología de Nanobodies para la adhesion dirigida de bacterias y la inyección de anticuerpos a células eucariotas

  • Luis Ángel Fernández Herrero (Investigador principal (IP))
  • RUANO GALLEGO, DAVID (Miembro de equipo)

Period: 01-01-2009 - 01-01-2012

Amount of funding: 263787,00 Euros.

  • iMarina

Angiobodies: Selección y optimización de anticuerpos recombinantes con utilidad diagnóstica y terapeútica en patología dependientes de angiogénesis

  • Luis Ángel Fernández Herrero (Investigador principal (IP))
  • RUANO GALLEGO, DAVID (Miembro de equipo)

Period: 01-01-2007 - 01-01-2011

Amount of funding: 650000,00 Euros.

  • iMarina

This researcher has no supervised thesis.

This researcher has no patents or software licenses.

Last data update: 3/19/24 12:53 AM